x

Oncocyte Corp (Nasdaq:OCX)

Health Care/Life Sciences • Biotechnology
CIK 1642380
Company

OncoCyte Corp. is a molecular diagnostics company, which engages in the development and commercialization of diagnostic tests for the detection of cancer, including molecular diagnostic services to pharmaceutical customers. Its products include DetermaRx and DetermaIO. The firm also offers pharmaceutical services like multi-analyte test development and clinical trial services. The company was founded in September 2009 and is headquartered in Alameda, CA.

Address
15 Cushing
Irvine, California 92618
Employees
46
Stock Info
Close
$3.6200
Day Range
2.9702 - 3.9500
52 Week Range
1.9220 - 3.9500
Average volume
96.44K
Short Interest
319.47K (02/14/25)
% of Float Shorted
2.16%
Market Cap
$76.25M
Revenue
$1.5M
Net Income
-$24.86M
2020 Sales Growth
N/A
Rev. per Employee
N/A
P/E Ratio
N/A
EPS
-$4.4303
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
President, Chief Executive Officer & Director
Joshua Riggs
Independent Director
Andrew J. Last
Lead Independent Director
Louis E. Silverman
SEC filings
DateFormEvent
9 Dec, 2024 SC 13G/A
9 Dec, 2024 4
14 Nov, 2024 SC 13G
12 Nov, 2024 8-K
12 Nov, 2024 10-Q
24 Oct, 2024 SC 13G/A
22 Oct, 2024 424B3
21 Oct, 2024 CORRESP
21 Oct, 2024 EFFECT
18 Oct, 2024 S-3/A
17 Oct, 2024 UPLOAD
16 Oct, 2024 S-3
15 Oct, 2024 8-K
15 Oct, 2024 4
9 Oct, 2024 SC 13G
8 Oct, 2024 D
4 Oct, 2024 4
4 Oct, 2024 4
3 Oct, 2024 8-K
25 Sep, 2024 DEF 14A
9 Aug, 2024 424B5
9 Aug, 2024 8-K
8 Aug, 2024 8-K
8 Aug, 2024 10-Q
7 Aug, 2024 CORRESP
7 Aug, 2024 EFFECT
6 Aug, 2024 UPLOAD
1 Aug, 2024 S-3
12 Jul, 2024 8-K
5 Jul, 2024 8-K
3 Jul, 2024 4
3 Jul, 2024 4
3 Jul, 2024 4
24 Jun, 2024 4
24 Jun, 2024 3
17 Jun, 2024 8-K
4 Jun, 2024 424B3
31 May, 2024 8-K
23 May, 2024 424B3
23 May, 2024 8-K
22 May, 2024 EFFECT
22 May, 2024 4
22 May, 2024 4
22 May, 2024 4
21 May, 2024 CORRESP
17 May, 2024 S-3/A
15 May, 2024 8-K
15 May, 2024 10-Q
14 May, 2024 UPLOAD
10 May, 2024 S-3
29 Apr, 2024 DEF 14A
25 Apr, 2024 D
22 Apr, 2024 SC 13G
16 Apr, 2024 10-K
15 Apr, 2024 4
15 Apr, 2024 4
15 Apr, 2024 4
15 Apr, 2024 SC 13D/A
12 Apr, 2024 8-K
11 Apr, 2024 8-K
1 Apr, 2024 NT 10-K
14 Feb, 2024 SC 13G/A
14 Feb, 2024 SC 13G/A
23 Jan, 2024 8-K
9 Nov, 2023 8-K
9 Nov, 2023 10-Q
12 Oct, 2023 4
10 Oct, 2023 8-K/A
5 Oct, 2023 8-K
20 Sep, 2023 8-K
28 Aug, 2023 8-K
17 Aug, 2023 4
10 Aug, 2023 8-K
10 Aug, 2023 10-Q
24 Jul, 2023 8-K
21 Jul, 2023 DEFA14A
10 Jul, 2023 DEF 14A
3 Jul, 2023 4
30 Jun, 2023 PRE 14A
29 Jun, 2023 8-K
27 Jun, 2023 4
27 Jun, 2023 4
27 Jun, 2023 4
27 Jun, 2023 4
15 Jun, 2023 4
13 Jun, 2023 4
9 Jun, 2023 8-K CEO Change
6 Jun, 2023 8-K
22 May, 2023 DEFR14A
19 May, 2023 DEF 14A
15 May, 2023 10-Q
11 May, 2023 8-K
1 May, 2023 10-K/A
18 Apr, 2023 4/A
18 Apr, 2023 4
14 Apr, 2023 SC 13G/A
13 Apr, 2023 8-K
12 Apr, 2023 10-K
7 Apr, 2023 4
7 Apr, 2023 SC 13D/A
6 Apr, 2023 8-K
6 Apr, 2023 424B5
5 Apr, 2023 4
5 Apr, 2023 4
5 Apr, 2023 4
5 Apr, 2023 8-K
3 Apr, 2023 NT 10-K
31 Mar, 2023 8-K
8 Mar, 2023 4
2 Mar, 2023 8-K CEO Change
28 Feb, 2023 4
28 Feb, 2023 4
23 Feb, 2023 8-K
17 Feb, 2023 8-K/A
14 Feb, 2023 SC 13G
14 Feb, 2023 SC 13G/A
14 Feb, 2023 SC 13G
13 Feb, 2023 8-K
3 Feb, 2023 8-K
30 Jan, 2023 8-K
19 Jan, 2023 4
19 Jan, 2023 4
19 Jan, 2023 4
28 Dec, 2022 4
28 Dec, 2022 4
27 Dec, 2022 4
22 Dec, 2022 4
21 Dec, 2022 8-K
20 Dec, 2022 4
20 Dec, 2022 4
9 Dec, 2022 4
9 Dec, 2022 3
9 Dec, 2022 3
5 Dec, 2022 8-K
23 Nov, 2022 8-K
10 Nov, 2022 10-Q
10 Nov, 2022 8-K
9 Nov, 2022 8-K
26 Sep, 2022 8-K
22 Sep, 2022 3
19 Aug, 2022 4
19 Aug, 2022 4
18 Aug, 2022 4
17 Aug, 2022 4
17 Aug, 2022 4
17 Aug, 2022 4
17 Aug, 2022 4
17 Aug, 2022 4
17 Aug, 2022 4
17 Aug, 2022 4
17 Aug, 2022 4
17 Aug, 2022 4
15 Aug, 2022 8-K
12 Aug, 2022 10-Q
10 Aug, 2022 8-K
8 Aug, 2022 3
3 Aug, 2022 8-K
1 Aug, 2022 8-K
28 Jul, 2022 SC 13D/A
21 Jul, 2022 8-K
19 Jul, 2022 4
19 Jul, 2022 4
19 Jul, 2022 4
19 Jul, 2022 4
19 Jul, 2022 4
19 Jul, 2022 4
15 Jul, 2022 8-K
30 Jun, 2022 8-K
28 Jun, 2022 4/A
28 Jun, 2022 4
15 Jun, 2022 4
13 Jun, 2022 3
8 Jun, 2022 DEF 14A
26 May, 2022 PRE 14A
19 May, 2022 4
12 May, 2022 10-Q
11 May, 2022 8-K
9 May, 2022 SC 13G
2 May, 2022 10-K/A
29 Apr, 2022 4/A
19 Apr, 2022 8-K
18 Apr, 2022 4
18 Apr, 2022 SC 13G
18 Apr, 2022 424B5
15 Apr, 2022 4
15 Apr, 2022 SC 13D/A
15 Apr, 2022 424B5
13 Apr, 2022 424B5
13 Apr, 2022 8-K
28 Mar, 2022 4
17 Mar, 2022 4
17 Mar, 2022 4
17 Mar, 2022 4
17 Mar, 2022 4
17 Mar, 2022 4
17 Mar, 2022 4
17 Mar, 2022 4
16 Mar, 2022 4
15 Mar, 2022 4
14 Mar, 2022 8-K
11 Mar, 2022 10-K
10 Mar, 2022 8-K
4 Feb, 2022 SC 13G
18 Jan, 2022 8-K
14 Dec, 2021 8-K
8 Dec, 2021 8-K
9 Nov, 2021 8-K
9 Nov, 2021 10-Q
4 Nov, 2021 8-K
27 Oct, 2021 8-K
14 Oct, 2021 4
14 Oct, 2021 3
7 Oct, 2021 8-K
24 Sep, 2021 4
24 Sep, 2021 SC 13D/A
20 Sep, 2021 8-K
11 Aug, 2021 10-Q
10 Aug, 2021 8-K
29 Jul, 2021 424B3
29 Jul, 2021 EFFECT
26 Jul, 2021 CORRESP
21 Jul, 2021 UPLOAD
20 Jul, 2021 8-K
14 Jul, 2021 S-3
7 Jul, 2021 S-8
2 Jul, 2021 4
2 Jul, 2021 4
28 Jun, 2021 4
28 Jun, 2021 8-K
28 Jun, 2021 4
28 Jun, 2021 4
28 Jun, 2021 4
28 Jun, 2021 4
28 Jun, 2021 4
24 Jun, 2021 8-K
14 Jun, 2021 8-K
14 Jun, 2021 4
14 Jun, 2021 424B5
8 Jun, 2021 EFFECT
4 Jun, 2021 CORRESP
3 Jun, 2021 UPLOAD
1 Jun, 2021 8-K/A
28 May, 2021 CORRESP
28 May, 2021 S-3
24 May, 2021 3
21 May, 2021 DEFA14A
21 May, 2021 DEF 14A
21 May, 2021 8-K
17 May, 2021 8-K
17 May, 2021 10-Q
10 May, 2021 PRE 14A
30 Apr, 2021 10-K/A
30 Apr, 2021 4
29 Apr, 2021 D
19 Apr, 2021 8-K
22 Mar, 2021 4
19 Mar, 2021 10-K
16 Mar, 2021 8-K
8 Mar, 2021 D
5 Mar, 2021 25
5 Mar, 2021 CERT
1 Mar, 2021 8-K
1 Mar, 2021 4
1 Mar, 2021 4
1 Mar, 2021 4
1 Mar, 2021 4
1 Mar, 2021 8-A12B
25 Feb, 2021 8-K
22 Feb, 2021 8-K
10 Feb, 2021 SC 13G/A
9 Feb, 2021 4
9 Feb, 2021 SC 13D/A
8 Feb, 2021 424B5
5 Feb, 2021 S-3MEF
5 Feb, 2021 8-K
4 Feb, 2021 8-K
4 Feb, 2021 424B5
3 Feb, 2021 8-K
2 Feb, 2021 SC 13G
2 Feb, 2021 8-K
28 Jan, 2021 3
28 Jan, 2021 SC 13G/A
22 Jan, 2021 4
22 Jan, 2021 SC 13D/A
21 Jan, 2021 8-K
21 Jan, 2021 424B5
8 Jan, 2021 SC 13D/A
Last update:2025-03-06 12:34:52.045442
Oncocyte Corp by TradingView

Sign Up to Subscribe